During the fiscal year, we had equity activity under one expired and two active share-based compensation plans. The expired plan consists of the 2008 Stock Incentive Plan (the “2008 Plan”). The active plans consist of the 2018 Stock Incentive Plan (the “2018 Plan”) and the 2018 Employee Stock Purchase Plan (the “2018 ESPP”). The plans are administered by the Compensation Committee of the Board of Directors, which consists of non-employee directors who are independent under the applicable listing standards for companies traded on the NASDAQ Stock Market LLC.

On August 22, 2018, our shareholders approved the 2018 Plan. The 2018 Plan permits the granting of stock options, stock appreciation rights, RSAs, RSUs, PSAs, PSUs, and other stock-based awards. The aggregate number of shares for issuance under the 2018 Plan will not exceed 2,000,000 shares and as of February 28, 2025, 493,635 shares were available for issuance.

On August 22, 2018, our shareholders approved the 2018 ESPP. The aggregate number of shares of common stock that may be purchased under the 2018 ESPP will not exceed 750,000 shares. Under the terms of the plan, associates may authorize the withholding of up to 15% of their wages or salaries to purchase our shares of common stock, not to exceed $25,000 of the fair market value of such shares for any calendar year. The purchase price for shares acquired under the 2018 ESPP is equal to the lower of 85% of the share's fair market value on either the first day of each option period or the last day of each period. The plan will expire by its terms on September 1, 2028. Shares of common stock purchased under the 2018 ESPP vest immediately at the time of purchase. During fiscal 2025, there were 52,826 shares purchased under the plan.


	Fiscal Years Ended Last Day of February,
(in thousands)	2025		2024		2023

Directors stock compensation	$	785	$	787	$	788
Service Condition Awards	11,407		12,345		8,663
Performance Condition Awards	3,611		5,746		9,017
Market Condition Awards	4,529		13,790		7,223
Employee stock purchase plan	1,044		1,204		1,062
Share-based compensation expense	21,376		33,872		26,753
Less: income tax benefits	(1,240)		(2,110)		(1,830)
Share-based compensation expense, net of income tax benefits	$	20,136	$	31,762	$	24,923

There have been no new grants of options since fiscal 2017 and all options outstanding at February 29, 2024 and February 28, 2025 were exercisable. A summary of stock option activity under our 2008 plan was as follows:


(in thousands, except contractual term and per share data)	Options	Weighted Average Exercise Price (per share)		Weighted Average Remaining Contractual Term (in years)	Intrinsic Value








Outstanding at February 29, 2024	10	$	72.46	0.5	$	447

Exercises	(6)	64.19			167

Outstanding at February 28, 2025	4	$	87.61	0.2	$	—
Exercisable at February 28, 2025	4	$	87.61	0.2	$	—

During fiscal 2025 we issued under the 2018 Plan, 9,752 RSAs to non-employee members of the Board of Directors with a total grant date fair value of $0.8 million or $80.53 per share. The RSAs vested immediately, and accordingly, were expensed immediately. The total fair value of RSAs granted to our non-employee members of the Board of Directors that vested immediately on grant dates in both fiscal 2024 and 2023 was $0.8 million.

We grant RSAs and RSUs to associates, which primarily vest ratably over three or four years or have specified graded vesting terms over 3 years, “Service Condition Awards”. A summary of Service Condition Awards activity during fiscal 2025 follows:



(in thousands, except per share data)	Number of Service Condition Awards	Weighted Average Grant Date Fair Value (per share)









Outstanding at February 29, 2024	180	$	138.06
Granted	191	99.20
Vested	(75)	153.39
Forfeited	(28)	126.07
Outstanding at February 28, 2025	268	$	107.29

The total fair value of Service Condition Awards that vested in fiscal 2025, 2024 and 2023 was $8.8 million, $6.2 million and $10.2 million, respectively. The weighted average grant date fair value of Service Condition Awards granted during fiscal 2025, 2024 and 2023 was $99.20, $109.97 and $195.90, respectively.

We grant Performance Condition Awards to certain officers and associates, which cliff vest after three years. The vesting of these awards is contingent upon meeting one or more defined operational performance metrics over a three year performance period. The quantity of shares ultimately awarded can range from 0% to 200% of “Target”, as defined in the award agreement as 100%, based on the level of achievement against the defined operational performance metrics. A summary of Performance Condition Awards activity during fiscal 2025 follows and reflects all PSAs granted and outstanding at maximum achievement of 200% of Target:



(in thousands, except per share data)	Number of Performance Condition Awards	Weighted Average Grant Date Fair Value (per share)



Outstanding at February 29, 2024	259	$	161.23
Granted	244	89.50
Vested	—	—
Forfeited (1)	(82)	197.04
Outstanding at February 28, 2025	421	$	112.67

No Performance Condition Awards vested in fiscal 2025. The total fair value of Performance Condition Awards that vested in fiscal 2024 and 2023 was $7.5 million and $37.8 million, respectively. The weighted average grant date fair value of Performance Condition Awards granted during fiscal 2025, 2024 and 2023 was $89.50, $110.83 and $204.20, respectively.

We grant Market Condition Awards to certain officers and associates, which cliff vest after three years. The vesting of these awards is contingent upon meeting specified stock price return targets compared to a predetermined peer group over a three year period. The quantity of shares ultimately awarded can range from 0% to 200% of “Target”, as defined in the award agreement as 100%, based on the level of

achievement against the defined targets. A summary of Market Condition Awards activity during fiscal 2025 follows and reflects all PSAs granted and outstanding at maximum achievement of 200% of Target:



(in thousands, except per share data)	Number of Market Condition Awards	Weighted Average Grant Date Fair Value (per share)



Outstanding at February 29, 2024	259	$	118.09
Granted	63	91.19
Vested	—	—
Forfeited (1)	(81)	143.59
Outstanding at February 28, 2025	241	$	102.48

No Market Condition Awards vested in fiscal 2025. The weighted average grant date fair value of Market Condition Awards granted during fiscal 2025, 2024 and 2023 was $91.19, $80.49 and $152.91, respectively.

The fair value of our Market Condition Awards are estimated using a Monte Carlo simulation model. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that market conditions will be achieved and is applied to the closing price of our common stock on the date of grant. The input variables utilized are included in the table below:


	Fiscal Years Ended Last Day of February,
	2025		2024		2023
Expected term in years	3		3		3
Risk free interest rate	4.3	%	4.6	%	1.5	%
Expected volatility	41.0	%	46.0	%	38.8	%
Expected dividend yield (1)	—	%	—	%	—	%

The expected term is consistent with the explicit service period and the risk free interest rate is based on U.S. Treasury securities with maturities equal to the expected term of the awards. Expected volatility is based equally on the historical volatility of our stock prices over the expected term of the awards and at-the-money call options traded on or near the grant date of the awards.

As of February 28, 2025, our total unrecognized share-based compensation for all awards was $26.8 million, which will be recognized over a weighted average amortization period of 2.2 years. The total unrecognized share-based compensation reflects an estimate of Target achievement for Performance Condition Awards granted during fiscal 2025 and 2024 and an estimate of zero percent of Target achievement for Performance Condition Awards granted during fiscal 2023.